• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

    1.590 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 72
    Open 1.590
    Bid (Size) 1.310 (1,000)
    Ask (Size) 1.650 (500)
    Prev. Close 1.590
    Today's Range 1.590 - 1.590
    52wk Range 0.5750 - 3.000
    Shares Outstanding 9,377,034
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements
    Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), today announce that... 
    Via Newsfile
    News headline image
    Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire

    Performance

    YTD
    +42.0%
    +42.0%
    1 Month
    +5.3%
    +5.3%
    3 Month
    +123.2%
    +123.2%
    6 Month
    +40.7%
    +40.7%
    1 Year
    -42.8%
    -42.8%

    More News

    Read More
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Taylor Morrison Home Corporation (NYSE - TMHC), Rallybio Corporation (Nasdaq – RLYB), InMed Pharmaceuticals, Inc. (Nasdaq – INM), KalVista Pharmaceuticals, Inc.
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether RAMP, NEE, INM, D are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether D, AVB, INM, EQR are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether SEM, WSR, INM, GDOT are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    InMed Pharmaceuticals Amends Preferred Investment Options
    Via Newsfile
    Discover the top movers in Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for December 11th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    What's Driving InMed's (INM) 22% After-Hours Surge? ↗
    Via Benzinga
    News headline image
    Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Science Virtual Investor Forum Agenda Announced for September 18th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Get insights into the top gainers and losers of Monday's after-hours session. ↗
    Via Chartmill
    News headline image
    Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data ↗
    Via Benzinga
    News headline image
    InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
    Via Newsfile
    Topics Regulatory Compliance
    News headline image
    InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
    Via Newsfile
    Topics Regulatory Compliance
    News headline image
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill
    BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
    Via Investor Brand Network
    News headline image
    Curious about the most active stocks on Tuesday? ↗
    Via Chartmill

    Frequently Asked Questions

    Is InMed Pharmaceuticals Inc. - Common Shares publicly traded?
    Yes, InMed Pharmaceuticals Inc. - Common Shares is publicly traded.
    What exchange does InMed Pharmaceuticals Inc. - Common Shares trade on?
    InMed Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for InMed Pharmaceuticals Inc. - Common Shares?
    The ticker symbol for InMed Pharmaceuticals Inc. - Common Shares is INM on the Nasdaq Stock Market
    What is the current price of InMed Pharmaceuticals Inc. - Common Shares?
    The current price of InMed Pharmaceuticals Inc. - Common Shares is 1.590
    When was InMed Pharmaceuticals Inc. - Common Shares last traded?
    The last trade of InMed Pharmaceuticals Inc. - Common Shares was at 07/15/26 04:00 PM ET
    What is the market capitalization of InMed Pharmaceuticals Inc. - Common Shares?
    The market capitalization of InMed Pharmaceuticals Inc. - Common Shares is 14.91M
    How many shares of InMed Pharmaceuticals Inc. - Common Shares are outstanding?
    InMed Pharmaceuticals Inc. - Common Shares has 15M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.